购物车
- 全部删除
- 您的购物车当前为空
CDN1163 是肌膜/内质网 Ca2+-ATPase (SERCA)的变构激活剂,可改善 Ca2+稳态,可减轻糖尿病和代谢紊乱。
为众多的药物研发团队赋能,
让新药发现更简单!
CDN1163 是肌膜/内质网 Ca2+-ATPase (SERCA)的变构激活剂,可改善 Ca2+稳态,可减轻糖尿病和代谢紊乱。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 289 | 现货 | |
2 mg | ¥ 397 | 现货 | |
5 mg | ¥ 638 | 现货 | |
10 mg | ¥ 987 | 现货 | |
25 mg | ¥ 1,980 | 现货 | |
50 mg | ¥ 3,570 | 现货 | |
100 mg | ¥ 5,230 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 688 | 现货 |
产品描述 | CDN1163 is a small molecule activator of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA). |
体内活性 | CDN1163, which markedly lowered fasting blood glucose, improved glucose tolerance, and ameliorated hepatosteatosis but did not alter glucose levels or body weight in lean controls.?Importantly, CDN1163-treated ob/ob mice maintained euglycemia comparable with that of lean mice for >6 weeks after cessation of CDN1163 administration[1]. |
分子量 | 320.39 |
分子式 | C20H20N2O2 |
CAS No. | 892711-75-0 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (156.06 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.